Road safety lead agency challenges of three decades of intervention for road safety in Iran: implications for policy-makers.


Journal

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention
ISSN: 1475-5785
Titre abrégé: Inj Prev
Pays: England
ID NLM: 9510056

Informations de publication

Date de publication:
02 2023
Historique:
received: 17 06 2022
accepted: 05 08 2022
pubmed: 24 8 2022
medline: 28 1 2023
entrez: 23 8 2022
Statut: ppublish

Résumé

Road traffic crashes and associated injuries and mortalities are one of the big public health challenges, especially in low/middle-income countries. Road safety lead agency (RSLA) is a vital factor in the sustainable prevention and promotes road safety. In the recent decades, various policy interventions have been conducted for road safety in Iran. This study aimed at exploring the challenges of RSLA from the perspectives of stakeholders at various levels. A qualitative study was conducted. In-depth interviews and document reviews were used for data collection. To conduct interviews, different stakeholders at various levels such as policy-makers, senior national authorities, researchers and faculty members were selected. Data collection was conducted between November 2019 and June 2020. Thematic content analysis approach was used for data analysis. The experts' perspectives were analysed and then categorised under five main themes including the role and position of the lead agency, the role and duties of the actors and players, translating policy into practice, intrasectoral and intersectoral cooperation and coordination and evidence production and application and a total of 22 subthemes were identified. The current structure of the RSLA is one of the main challenges emphasised by the research participants. To achieve significant improvements in road safety at the national level, a strong management system and leadership body is a critical issue. Organisational reform to establish an effective unique lead agency is proposed to cope with RSLA challenges.

Sections du résumé

BACKGROUND
Road traffic crashes and associated injuries and mortalities are one of the big public health challenges, especially in low/middle-income countries. Road safety lead agency (RSLA) is a vital factor in the sustainable prevention and promotes road safety. In the recent decades, various policy interventions have been conducted for road safety in Iran. This study aimed at exploring the challenges of RSLA from the perspectives of stakeholders at various levels.
METHODS
A qualitative study was conducted. In-depth interviews and document reviews were used for data collection. To conduct interviews, different stakeholders at various levels such as policy-makers, senior national authorities, researchers and faculty members were selected. Data collection was conducted between November 2019 and June 2020. Thematic content analysis approach was used for data analysis.
RESULTS
The experts' perspectives were analysed and then categorised under five main themes including the role and position of the lead agency, the role and duties of the actors and players, translating policy into practice, intrasectoral and intersectoral cooperation and coordination and evidence production and application and a total of 22 subthemes were identified. The current structure of the RSLA is one of the main challenges emphasised by the research participants.
CONCLUSION
To achieve significant improvements in road safety at the national level, a strong management system and leadership body is a critical issue. Organisational reform to establish an effective unique lead agency is proposed to cope with RSLA challenges.

Identifiants

pubmed: 35999042
pii: ip-2022-044685
doi: 10.1136/ip-2022-044685
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-21

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Homayoun Sadeghi-Bazargani (H)

Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Alireza Razzaghi (A)

Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran alirezarazzaghi_21@yahoo.com.

Mohammad Hossein Somi (MH)

Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Leila Doshmangir (L)

Department of Health Policy & Management Research Center, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.

Alireza Esmaeili (A)

Department of Traffic and Transportation, Faculty of Traffic University of Police, Tehran, Iran.

Javad Hedayati (J)

General Manager of Strategic Studies of Road Maintenance and Transportation (RMTO) Studies Department, Tehran, Iran.

Seyyed Teymoor Hosseini (ST)

Department of Engineering Traffic and transportation, Faculty of Traffic University of Police, Tehran, Iran.

Hamidreza Khankeh (H)

Health in Emergency and Disaster Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Alireza Khavandi Khiavi (AK)

Department of Civil Engineering, Faculty of Engineering, University of Zanjan, Zanjan, Iran.

Reza Masoudi Far (RM)

Social Deputy of the Judiciary, Islamic Republic of Iran, Tehran, Iran.

Pooria Mohammadian (P)

Transport Office of Ministry of Interior and Secretary of High Council for Urban Traffic Coordination of Iran, Tehran, Iran.

Saeid Pour-Doulati (S)

Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mahdi Rezaei (M)

Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Saadati (M)

Department of Public health, Khoy University of Medical Sciences, Khoy, Iran.

Jabbar Ali Zakeri (JA)

Center of Excellence for Railway Transportation, School of Railway Engineering, Iran University of Science and Technology, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH